Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. ENTX.NASDAQ

Entera Bio Ltd (ENTX NASDAQ) stock market data APIs

$1.75 0.06(3.6%) as of July 26, 2024
Price chart is built with Anychart

Entera Bio Ltd., a clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs where an oral tablet form holds the potential to transform the standard of care. The company leverage its N-Tab, an oral delivery technology, which is designed to simultaneously stabilize the peptide in the gastrointestinal tract and promote its absorption into the bloodstream. Its advanced product candidate is EB613 (oral PTH (1-34)) that is entering into Phase 3 development as the first oral, osteoanabolic (bone-building) once-daily tablet treatment for post-menopausal women with low bone mineral density and high-risk osteoporosis. The company is also developing EB612 as the first oral PTH(1-34) tablet peptide replacement therapy for hypoparathyroidism. In addition, it is developing the first oral oxyntomodulin, a dual targeted GLP1/glucagon peptide, in tablet form for the treatment of obesity; and the first oral GLP-2 peptide tablet as an injection-free alternative for patients suffering from rare malabsorption conditions, such as short bowel syndrome. The company has research collaboration agreement with OPKO Biologics, Inc. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.

Entera Bio Ltd Financial Data Overview

1.69
1.75
-
1.75
1.65
0.52-3.35
62 700 K
36 035 K
14 000
-0.05
1.607
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ENTX',
Type: 'Common Stock',
Name: 'Entera Bio Ltd',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000R1K184',
ISIN: 'IL0011429839',
CUSIP: 'M40527109',
CIK: '1638097',
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '2018-06-28',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'ADR Primary',
IsDelisted: false,
}

Entera Bio Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 14 000
  • EBITDA -8 686 000
  • Earnings Per Share -0.28
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Entera Bio Ltd Earnings via APIs

  • Latest Release 2024-05-10
  • EPS/Forecast -0.06

Get Entera Bio Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Entera Bio Ltd latest news via APIs

3 Meme Stocks to Buy on the Dip: June 2024

When meme stocks start skyrocketing, it’s difficult to find a good entry point. Already, examples of a big rally in meme stocks happened in the recent past. In just over a month, Novavax (NASDAQ:NV...

Rags to Riches: 3 Penny Stocks That Could Make Early Investors Rich

There are penny stocks to buy that represent purely speculative bets. In a meme frenzy, these stocks can deliver multibagger returns in the blink of an eye. However, some high-risk but extremely prom...
Do you have any questions?
support@eodhistoricaldata.com